UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Effect of IBD medications on COVID-19 outcomes: results from an international registry

Gut, 2021-04, Vol.70 (4), p.725-732

2021

Volltextzugriff (PDF)

Besting the Biologics: Vancomycin Monotherapy for Ulcerative Colitis Management in Patients with Primary Sclerosing Cholangitis

Digestive diseases and sciences, 2023-04, Vol.68 (4), p.1118-1120

2023

Volltextzugriff (PDF)

Impact of SARS-CoV-2 Vaccination on Inflammatory Bowel Disease Activity and Development of Vaccine-Related Adverse Events: Results From PREVENT-COVID

Inflammatory bowel diseases, 2022-10, Vol.28 (10), p.1497-1505

2022

Volltextzugriff (PDF)

Impact of Medications on COVID-19 Outcomes in Inflammatory Bowel Disease: Analysis of More Than 6000 Patients From an International Registry

Gastroenterology (New York, N.Y. 1943), 2022-01, Vol.162 (1), p.316-319.e5

2022

Volltextzugriff (PDF)

Inflammatory Pouch Conditions Are Common After Ileal Pouch Anal Anastomosis in Ulcerative Colitis Patients

Inflammatory bowel diseases, 2020-06, Vol.26 (7), p.1079-1086

2020

Volltextzugriff (PDF)

Managing IBD in the COVID-19 era

Therapeutic Advances in Gastroenterology, 2023-01, Vol.16, p.17562848231176450

2023

Volltextzugriff (PDF)

Early Use of Biologics Reduces Healthcare Costs in Crohn’s Disease: Results from a United States Population-Based Cohort

Digestive diseases and sciences, 2024, Vol.69 (1), p.45-55

2024

Volltextzugriff (PDF)

Approach to the Management of Recently Diagnosed Inflammatory Bowel Disease Patients: A User’s Guide for Adult and Pediatric Gastroenterologists

Gastroenterology (New York, N.Y. 1943), 2021-07, Vol.161 (1), p.47-65

2021

Volltextzugriff (PDF)

Editorial/introduction to special issue

Current research in pharmacology and drug discovery, 2022, Vol.3, p.100125-100125, Article 100125

2022

Volltextzugriff (PDF)

Inflammatory Bowel Disease Is Associated With Prediagnostic Perturbances in Metabolic Pathways

Gastroenterology (New York, N.Y. 1943), 2023-01, Vol.164 (1), p.147-150.e2

2023

Volltextzugriff (PDF)

What Should Gastroenterologists and Patients Know About COVID-19?

Clinical gastroenterology and hepatology, 2020-06, Vol.18 (7), p.1409-1411

2020

Volltextzugriff (PDF)

Development and validation of multivariable prediction models for adverse COVID-19 outcomes in patients with IBD

BMJ open, 2021-11, Vol.11 (11), p.e049740-e049740

2021

Volltextzugriff (PDF)

Corticosteroids, But Not TNF Antagonists, Are Associated With Adverse COVID-19 Outcomes in Patients With Inflammatory Bowel Diseases: Results From an International Registry

Gastroenterology (New York, N.Y. 1943), 2020-08, Vol.159 (2), p.481-491.e3

2020

Volltextzugriff (PDF)

COVID-19 mRNA Vaccine Short-Term Safety in Patients With Inflammatory Bowel Disease

Gastroenterology (New York, N.Y. 1943), 2022-03, Vol.162 (3), p.987-988

2022

Volltextzugriff (PDF)

Unmet needs in inflammatory bowel disease

Current research in pharmacology and drug discovery, 2021-01, Vol.2, p.100070-100070, Article 100070

2021

Volltextzugriff (PDF)

Autoimmune and Chronic Inflammatory Disease Patients with COVID‐19

ACR open rheumatology, 2021-02, Vol.3 (2), p.111-115

2021

Volltextzugriff (PDF)

Systematic review and meta‐analysis: efficacy and safety of early biologic treatment in adult and paediatric patients with Crohn’s disease

Alimentary pharmacology & therapeutics, 2020-05, Vol.51 (9), p.831-842

2020

Volltextzugriff (PDF)

Is Prevention the Best Way to Modify Inflammatory Bowel Disease? How Close Are We?

Gastroenterology (New York, N.Y. 1943), 2022-04, Vol.162 (5), p.1452-1455

2022

Volltextzugriff (PDF)

Shorter Crohn’s Disease Duration Is Associated With Better Clinical and Endoscopic Outcomes With Risankizumab in Phase 3 Studies

Gastro hep advances, 2024, Vol.3 (4), p.539-550

2024

Volltextzugriff (PDF)

High Levels of Psychological Resilience Associated With Less Disease Activity, Better Quality of Life, and Fewer Surgeries in Inflammatory Bowel Disease

Inflammatory bowel diseases, 2021-05, Vol.27 (6), p.791-796

2021

Volltextzugriff (PDF)

Reappraisal of Coronavirus Disease 2019 Risk for Patients With Inflammatory Bowel Disease: Withdrawal of the British Society of Gastroenterology Inflammatory Bowel Disease Risk Grid

Gastroenterology (New York, N.Y. 1943), 2023-01, Vol.164 (1), p.2-4

2023

Volltextzugriff (PDF)

Early Ileocecal Resection for Crohn’s Disease Is Associated With Improved Long-term Outcomes Compared With Anti-Tumor Necrosis Factor Therapy: A Population-Based Cohort Study

Gastroenterology (New York, N.Y. 1943), 2023-10, Vol.165 (4), p.976-985.e3

2023

Volltextzugriff (PDF)

De-escalation of Therapy for Patients With Inflammatory Bowel Disease

Gastroenterology & hepatology, 2022-04, Vol.18 (4), p.213-215

Ungaro, Ryan C

2022

Volltextzugriff (PDF)

Targeting the Interleukin 23 Pathway in Inflammatory Bowel Disease

Gastroenterology (New York, N.Y. 1943), 2024-06

2024

Volltextzugriff (PDF)

Net Remission Rates with Biologic and Small Molecule Treatment in Ulcerative Colitis: A Reappraisal of the Clinical Trial Data

Clinical gastroenterology and hepatology, 2023-12, Vol.21 (13), p.3433-3436.e1

2023

Volltextzugriff (PDF)

1 – 25 von 805

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(718)
Mit Volltextzugriff
(698)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(355)
Life Sciences & Biomedicine
(269)
Humans
(201)
Gastroenterology & Hepatology
(108)
Female
(99)
Male
(94)
Physical Sciences
(75)
Adult
(72)
Physics
(68)
Middle Aged
(60)
Inflammatory Bowel Disease
(55)
Animals
(49)
Aged
(38)
Biological And Medical Sciences
(38)
Mice
(38)
Ulcerative Colitis
(36)
Crohn's Disease
(33)
General & Internal Medicine
(32)
Nuclear Physics And Radiation Physics
(32)
Covid-19
(29)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Effect of IBD medications on COVID-19 outcomes: results from an international registry

Besting the Biologics: Vancomycin Monotherapy for Ulcerative Colitis Management in Patients with Primary Sclerosing Cholangitis

Impact of SARS-CoV-2 Vaccination on Inflammatory Bowel Disease Activity and Development of Vaccine-Related Adverse Events: Results From PREVENT-COVID

Impact of Medications on COVID-19 Outcomes in Inflammatory Bowel Disease: Analysis of More Than 6000 Patients From an International Registry

Inflammatory Pouch Conditions Are Common After Ileal Pouch Anal Anastomosis in Ulcerative Colitis Patients

Managing IBD in the COVID-19 era

Early Use of Biologics Reduces Healthcare Costs in Crohn’s Disease: Results from a United States Population-Based Cohort

Approach to the Management of Recently Diagnosed Inflammatory Bowel Disease Patients: A User’s Guide for Adult and Pediatric Gastroenterologists

Editorial/introduction to special issue

Inflammatory Bowel Disease Is Associated With Prediagnostic Perturbances in Metabolic Pathways

What Should Gastroenterologists and Patients Know About COVID-19?

Development and validation of multivariable prediction models for adverse COVID-19 outcomes in patients with IBD

Corticosteroids, But Not TNF Antagonists, Are Associated With Adverse COVID-19 Outcomes in Patients With Inflammatory Bowel Diseases: Results From an International Registry

COVID-19 mRNA Vaccine Short-Term Safety in Patients With Inflammatory Bowel Disease

Unmet needs in inflammatory bowel disease

Autoimmune and Chronic Inflammatory Disease Patients with COVID‐19

Systematic review and meta‐analysis: efficacy and safety of early biologic treatment in adult and paediatric patients with Crohn’s disease

Is Prevention the Best Way to Modify Inflammatory Bowel Disease? How Close Are We?

Shorter Crohn’s Disease Duration Is Associated With Better Clinical and Endoscopic Outcomes With Risankizumab in Phase 3 Studies

High Levels of Psychological Resilience Associated With Less Disease Activity, Better Quality of Life, and Fewer Surgeries in Inflammatory Bowel Disease

Reappraisal of Coronavirus Disease 2019 Risk for Patients With Inflammatory Bowel Disease: Withdrawal of the British Society of Gastroenterology Inflammatory Bowel Disease Risk Grid

Early Ileocecal Resection for Crohn’s Disease Is Associated With Improved Long-term Outcomes Compared With Anti-Tumor Necrosis Factor Therapy: A Population-Based Cohort Study

De-escalation of Therapy for Patients With Inflammatory Bowel Disease

Targeting the Interleukin 23 Pathway in Inflammatory Bowel Disease

Net Remission Rates with Biologic and Small Molecule Treatment in Ulcerative Colitis: A Reappraisal of the Clinical Trial Data

Suchergebnisse filtern